Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 25,267 - -
Change - -49.85% 49.53% -8.95% -16.56% 27.65% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 24,759 24,526 24,305
Change - -51.82% 51.78% -7.74% -18.07% 28.91% -0.94% -0.9%
P/E 54.1x 30.4x 44.7x 49x 40.5x 42.5x 37.2x 33.5x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 8.08x 7.13x 6.27x
PEG - -2.8x 23.04x -3.2x 27.09x 1.8x 2.6x 3x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.58x 7.14x 6.66x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.43x 6.93x 6.41x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 26.8x 24.1x 21.5x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 33.4x 29.8x 26.4x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 53.9x 45.5x 37.5x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.85% 2.2% 2.66%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.8774 0.9571 1.094
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.25% 0.27% 0.31%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.416 9.619 10.68
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.4% 9.95% 10.2%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,333 3,537 3,792
EBITDA 1 884.7 882.6 827.9 728.2 793.8 923.3 1,017 1,129
EBIT 1 762.4 762 690.6 572.8 622.4 741.1 823.5 922
Net income 1 661.8 585.9 593.4 492.7 493.7 604.2 685.6 754.9
Net Debt 1 - -685.4 -647.1 -282 -588.5 -508.1 -741.3 -961.7
Reference price 2 469.01 235.35 352.12 327.56 275.14 357.65 357.65 357.65
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,648 - -
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
42.5x7.43x26.82x0.25% 25.27B
22x3.32x12.36x2.86% 155B
17.99x3.16x11.14x3.74% 102B
16.81x0.19x11.89x0.78% 58.81B
32.32x7.84x20.51x1.24% 52.82B
37.54x2.99x10.27x2.56% 41.51B
37.06x1.36x11.95x0.21% 32.69B
30.28x5.4x17.21x-.--% 28.6B
22.96x3.36x12.09x1.26% 20.34B
47.92x6.43x20.66x0.45% 20.99B
Average 30.74x 4.15x 15.49x 1.34% 53.75B
Weighted average by Cap. 26.26x 3.67x 13.94x 2.03%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Valuation West Pharmaceutical Services, Inc.